MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nmd.2021.09.008

Медицинская библиотека · Neuromuscular disorders : NMD · 2021

Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.

Koutsis Georgios, Kastritis Efstathios, Kontogeorgiou Zoi, Kartanou Chrisoula, Kokotis Panagiotis, Rentzos Michail, Breza Marianthi, Kleopa Kleopas A, Christodoulou Kyproula, Oikonomou Evangelos, Anastasakis Aris, Angelidakis Panagiotis, Sarmas Ioannis, Kargiotis Odysseas, Tzagournissakis Minas, Zaganas Ioannis, Foukarakis Emmanouil, Sachpekidis Vasileios, Papathoma Alexandra, Panas Marios, Stefanis Leonidas, Dimopoulos Meletios Athanasios, Karadima Georgia

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Comprehensive data on variant transthyretin amyloidosis polyneuropathy (ATTRv-PN) in Greece are lacking. We presently provide an overview of ATTRv-PN in Greece, focusing on unexplored non-endemic regions of the country. In total, we identified 57 cases of ATTRv-PN diagnosed over the past 25 years, including 30 from the island of Crete, an apparent endemic region. Patients carried 10 different TTR mutations (C10R; P24S; V30M; R34G; R34T; I68L; A81T; E89Q; E89K and V94A). Carriers of the common V30M mutation constituted 54.3 % of the cohort. A known founder effect for the V30M mutation was present on the island of Crete. Non-endemic cases identified outside the island of Crete are presently reported in more detail. The age of onset ranged from 25 to 77 years, with a mean of 51.1 years. A mean diagnostic delay of 3.2 years was observed. V30M patients had earlier onset and less cardiac involvement than patients carrying other mutations. Genotype-phenotype correlations were largely consistent with published data. We conclude that, with the exception of the Cretan cluster, ATTRv-PN is not endemic in the Greek population. This makes timely diagnosis more challenging, yet absolutely essential given the availability of therapies that can alter the long-term course of the disease.

Для цитирования: Koutsis Georgios, Kastritis Efstathios, Kontogeorgiou Zoi, Kartanou Chrisoula, Kokotis Panagiotis, Rentzos Michail, Breza Marianthi, Kleopa Kleopas A, Christodoulou Kyproula, Oikonomou Evangelos, Anastasakis Aris, Angelidakis Panagiotis, Sarmas Ioannis, Kargiotis Odysseas, Tzagournissakis Minas, Zaganas Ioannis, Foukarakis Emmanouil, Sachpekidis Vasileios, Papathoma Alexandra, Panas Marios, Stefanis Leonidas, Dimopoulos Meletios Athanasios, Karadima Georgia. Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.. Neuromuscular disorders : NMD. 2021. DOI: 10.1016/j.nmd.2021.09.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.